New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Beyond Identity Raises $75 Million to Take Customers Beyond Passwordless to the Identity Platform of the Future
-
Form 4 Regulus Therapeutics For: Dec 04 Filed by: New Enterprise Associates 16, L.P.
-
Fugue Appoints Josh Stella as CEO and David Mitchell as President and COO
-
FiscalNote Secures $160 Million in Financing and Growth Capital
-
FiscalNote Secures $160 Million in Financing and Growth Capital
-
Qpex Biopharma Initiates Phase 1 Clinical Trial of QPX7728 for Drug-Resistant Bacterial Infections
-
CIT Invests in CySecure to Advance the Next Generation of Identity and Authentication Solutions
-
Strive Health Welcomes Brandi Riddle as Chief Financial Officer
-
BioInnovation Institute takes in new cohort of promising early-stage innovations
-
Metromile, a Leading Digital Insurance Platform, to Become Public Company via Merger with INSU Acquisition Corp. II (INAQ)
-
Metromile, a Leading Digital Insurance Platform, to Become Public Company
-
Metromile, a Leading Digital Insurance Platform, to Become Public Company
-
Lumos Pharma to Participate in December Investor Conferences
-
Lumos Pharma to Participate in December Investor Conferences
-
Correlia Biosystems Closes $7M Series A to Enable Product Launch
-
Form SC 13D/A Mersana Therapeutics, Filed by: New Enterprise Associates 14, L.P.
-
Duolingo Raises $35 Million to Fuel Continued Global Growth
-
Moderne Ventures Invests in Stride to Bring Portable Benefits to Every Real Estate Agent
-
PIONYR Immunotherapeutics Initiates Phase 1 Clinical Study Of PY314
-
Form 4 Sprout Social, Inc. For: Nov 13 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Hydrus Microstent Receives Highest Designation of Any MIGS Device as Part of AAO Treatment Guidelines
-
Futuro Health Launches Health IT Specialist Training Program on Leading Online Learning Platform, Coursera
-
CIT GAP Funds Named Virginia’s Most Active Investor by CB Insights in 2020
-
Form 4 Cloudflare, Inc. For: Nov 11 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Woebot Health Strengthens Product Vision By Naming Joseph Gallagher to Vice President of Product
-
Postmates, Uber, and DoorDash, and More Join Forces with Get America Covered and Stride Health to Increase the Number of Americans Enrolled in Affordable Health Insurance for 2021
-
Sonatype and Fugue Partner to Shift Cloud Security Left and Ensure Continuous Policy Compliance
-
Sonatype and Fugue Partner to Shift Cloud Security Left and Ensure Continuous Policy Compliance
-
CIT’s Virginia Founders Fund Invests in Mesh Intelligence to Manage the Global Food Supply Chain Risk
-
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
-
Lumos Pharma Announces the Initiation of Phase 2b OraGrowtH210 Trial and Reports Third Quarter 2020 Financial Results
-
Semantix, Latin American Analytics Leader, Chooses OmniSci To Bring Accelerated Visualization to Its Offerings
-
Direct Primary Care Provider Paladina Health Changes Name to Everside Health
-
Korro Bio Appoints Ram Aiyar, Ph.D., MBA, as Chief Executive Officer
-
Form SC 13D/A Senseonics Holdings, Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Privitar and StreamSets Announce New Partnership and Product Integration That Helps Organizations Accelerate Access to Data-Driven Insights by De-Risking Their Data Pipelines
-
Topia Named Strategic Leader in the new Fosway 9-Grid™ for Talent & People Success
-
Timescale Launches Industry’s First Multi-Node Relational Database for Time-Series Data, Giving Organizations Unprecedented Scale
-
Relievant Medsystems Announces $70M Financing to Accelerate U.S. Commercialization of Intracept Procedure
-
Lumos Pharma to Participate in November Investor Conferences
-
Lumos Pharma to Participate in November Investor Conferences
-
Strive Health Partners with Nearly 200 Nephrology Providers Across Multiple States to Implement Innovative Medicare Kidney Care Program
-
Strive Health Partners with Nearly 200 Nephrology Providers Across Multiple States to Implement Innovative Medicare Kidney Care Program
-
Form SC 13D Eargo, Inc. Filed by: New Enterprise Associates 15, L.P.
-
Lumos Pharma to Report Third Quarter 2020 Financial Results and Host a Conference Call on November 10, 2020
-
Lumos Pharma to Report Third Quarter 2020 Financial Results and Host a Conference Call on November 10, 2020
-
MBX Biosciences Appoints James Cornelius to its Board of Directors
-
STAGE ACCESS™ Launches North America "Opening Night" Week Beginning Monday, October 26th
-
Video Telematics Leader Lytx Selects OmniSci Accelerated Analytics Platform to Help Fleets Reduce Risk and Improve Safety
-
CIT GAP Funds and The Pearl Fund Lead $3M Opportunity Zone Investment in Micronic Technologies

